AIThe Next Webabout 3 hours ago
Cambridge startup builds chest AI model for drug trials
1 min read
Qureight raised $20 million in Series B funding led by Molten Ventures to build a general-purpose 3D AI model of the chest. The model cuts drug trial imaging decisions from two weeks to 48 hours. AstraZeneca and Bristol Myers Squibb already use the platform.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
